IgGenix to Showcase Groundbreaking Alpha-gal Antibody Discovery at 2025 AAAAI / WAO Congress IgGenix will reveal its innovative monoclonal antibody discoveries for Alpha-gal Syndrome at the 2025 AAAAI / WAO Joint Congress, enhancing our understanding of this red meat allergy.

IgGenix to Showcase Groundbreaking Alpha-gal Antibody Discovery at 2025 AAAAI / WAO Congress #United_States #San_Diego #Monoclonal_Antibodies #IgGenix #Alpha-gal_Syndrome

🔬Study Overview-
• Name of Research Study: IgGenix ACCELERATE Peanut Study
• Area of Allergy Research: Food Allergies (Peanuts)
• Research for: Teens and Adults (15 to 55)
• Location of Study: Western Australia, New South Wales and Victoria

#peanutallergy #peanutallergies #iggenix